ArticleEMBO molecular medicine2023
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model.
Marco Peviani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it